Donata Hoffmann

7.2k total citations
127 papers, 3.6k citations indexed

About

Donata Hoffmann is a scholar working on Infectious Diseases, Epidemiology and Agronomy and Crop Science. According to data from OpenAlex, Donata Hoffmann has authored 127 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 54 papers in Epidemiology and 35 papers in Agronomy and Crop Science. Recurrent topics in Donata Hoffmann's work include Viral Infections and Vectors (35 papers), Animal Disease Management and Epidemiology (35 papers) and Influenza Virus Research Studies (25 papers). Donata Hoffmann is often cited by papers focused on Viral Infections and Vectors (35 papers), Animal Disease Management and Epidemiology (35 papers) and Influenza Virus Research Studies (25 papers). Donata Hoffmann collaborates with scholars based in Germany, United States and Switzerland. Donata Hoffmann's co-authors include Martin Beer, Thomas C. Mettenleiter, Timm Harder, Kerstin Wernike, Bernd Hoffmann, Donata Kalthoff, Kore Schlottau, Dirk W. Höper, Angele Breithaupt and Christian Grund and has published in prestigious journals such as Nature Communications, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Donata Hoffmann

120 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Donata Hoffmann 2.1k 1.2k 904 744 497 127 3.6k
Changchun Tu 1.6k 0.8× 506 0.4× 930 1.0× 964 1.3× 351 0.7× 167 3.4k
Alejandro Núñez 1.2k 0.6× 922 0.8× 1.0k 1.1× 413 0.6× 297 0.6× 149 2.8k
Paul-Pierre Pastoret 1.1k 0.5× 1.4k 1.1× 942 1.0× 487 0.7× 301 0.6× 204 3.8k
Xianzhu Xia 2.0k 0.9× 2.0k 1.7× 811 0.9× 818 1.1× 222 0.4× 233 4.4k
H. A. Westbury 1.6k 0.8× 1.7k 1.4× 934 1.0× 800 1.1× 324 0.7× 71 3.0k
Ken Maeda 2.0k 0.9× 1.1k 0.9× 213 0.2× 543 0.7× 543 1.1× 233 3.5k
Emmanuel Couacy‐Hymann 1.1k 0.5× 1.4k 1.2× 1.2k 1.3× 407 0.5× 392 0.8× 87 3.2k
Sergio Rosati 712 0.3× 1.2k 1.0× 749 0.8× 340 0.5× 260 0.5× 127 3.1k
Dolores Gavier‐Widén 1.5k 0.7× 768 0.6× 685 0.8× 465 0.6× 263 0.5× 102 3.1k
Pablo R. Murcia 1.5k 0.7× 1.8k 1.5× 624 0.7× 395 0.5× 283 0.6× 83 3.2k

Countries citing papers authored by Donata Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Donata Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donata Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donata Hoffmann more than expected).

Fields of papers citing papers by Donata Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donata Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donata Hoffmann. The network helps show where Donata Hoffmann may publish in the future.

Co-authorship network of co-authors of Donata Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Donata Hoffmann. A scholar is included among the top collaborators of Donata Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donata Hoffmann. Donata Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ulrich, Lorenz, Kore Schlottau, Nico Joël Halwe, et al.. (2025). Characterization of monkeypox virus clade IIb lineage B1 strains in animal models: insights into virulence. Emerging Microbes & Infections. 14(1). 2508762–2508762.
2.
Eisenberg, Tobias, Elisa Heuser, Johannes Dreesman, et al.. (2024). Cuddle with care! A current overview of zoonotic pathogens transmitted by pet rats. OpenAgrar.
3.
Jacob, Jens, Michael Brecht, Julia Sehl‐Ewert, et al.. (2024). Detection of novel orthoparamyxoviruses, orthonairoviruses and an orthohepevirus in European white-toothed shrews. Microbial Genomics. 10(8).
4.
Schön, Jacob, Donata Hoffmann, Nico Joël Halwe, et al.. (2024). High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters. npj Vaccines. 9(1). 206–206. 1 indexed citations
5.
Ulrich, Lorenz, Nicole Roth, Julius Beer, et al.. (2024). mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice. Molecular Therapy — Nucleic Acids. 35(4). 102360–102360.
6.
Pfaff, Florian, Lorenz Ulrich, Nico Joël Halwe, et al.. (2023). SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice. European Journal of Immunology. 53(12). e2250332–e2250332. 3 indexed citations
7.
Roth, Nicole, Stefan O. Mueller, Lorenz Ulrich, et al.. (2023). Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models. Vaccines. 11(2). 318–318. 6 indexed citations
8.
Corleis, Björn, Donata Hoffmann, Susanne Rauch, et al.. (2023). Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature Communications. 14(1). 816–816. 15 indexed citations
9.
Wernike, Kerstin, Mark Holsteg, Andrea Aebischer, et al.. (2022). Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus. Transboundary and Emerging Diseases. 69(5). e3289–e3296. 14 indexed citations
10.
Roth, Nicole, Jacob Schön, Donata Hoffmann, et al.. (2022). Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses. Vaccines. 10(8). 1251–1251. 16 indexed citations
11.
Cadar, Dániel, Rainer G. Ulrich, Kore Schlottau, et al.. (2021). Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany. Emerging Microbes & Infections. 10(1). 602–611. 15 indexed citations
12.
Michelitsch, Anna, Jacob Schön, Donata Hoffmann, Martin Beer, & Kerstin Wernike. (2021). The Second Wave of SARS-CoV-2 Circulation—Antibody Detection in the Domestic Cat Population in Germany. Viruses. 13(6). 1009–1009. 27 indexed citations
13.
Schön, Jacob, et al.. (2020). A modified live bat influenza A virus-based vaccine prototype provides full protection against HPAIV H5N1. npj Vaccines. 5(1). 40–40. 6 indexed citations
14.
Wolff, J. W., et al.. (2020). Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus. Vaccines. 9(1). 4–4. 49 indexed citations
15.
Wernike, Kerstin, Andrea Aebischer, Anna Michelitsch, et al.. (2020). Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals. Transboundary and Emerging Diseases. 68(4). 1779–1785. 64 indexed citations
16.
Wolff, J. W., Jacqueline King, Anne Pohlmann, et al.. (2020). Experimental Infection and Genetic Characterization of Two Different Capripox Virus Isolates in Small Ruminants. Viruses. 12(10). 1098–1098. 19 indexed citations
17.
Schlottau, Kore, et al.. (2020). First isolation, in-vivo and genomic characterization of zoonotic variegated squirrel Bornavirus 1 (VSBV-1) isolates. Emerging Microbes & Infections. 9(1). 2474–2484. 3 indexed citations
19.
Grund, Christian, Donata Hoffmann, Reiner Ulrich, et al.. (2018). A novel European H5N8 influenza A virus has increased virulence in ducks but low zoonotic potential. Emerging Microbes & Infections. 7(1). 1–14. 65 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026